Pfizer Settles a Drug Marketing Case for $491 Million

The Justice Department announced that the drug maker would settle criminal and civil charges over illegal marketing of the kidney-transplant drug Rapamune.

    

Powered by WPeMatico

Share
This entry was posted in Science. Bookmark the permalink.

Comments are closed.